[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Akinator Assets [@AkinatorAssets](/creator/twitter/AkinatorAssets) on x XXX followers Created: 2025-07-09 15:43:40 UTC đ§”3/ BULL CASE â $HIMS đ BULL CASE: 1.Exceptional Revenue Growth Trajectory: $HIMS has delivered XXXXX% YoY revenue growth. Its Q1 2025 earnings highlighted âmillions of people turning to usâ and âincredible momentumâ â a clear signal of strong consumer adoption and traction. 2.GLP-1 Expansion Success: $HIMS is a key player in offering FDA-approved GLP-1 medications for weight loss via telehealth. With personalized plans and licensed professionals, management expects $725M in weight loss revenue alone in 2025. 3.Industry Tailwinds: The global telehealth market is projected to reach $455.27B by 2030, growing at XXXXX% CAGR. $HIMS is well-positioned to capture a meaningful share of that pie. 4.Strong Profitability Metrics: Despite being a high-growth company, $HIMS is already posting a XXXX% profit margin, outperforming peers who are still bleeding cash for growth. 5.Aggressive Revenue Guidance: $HIMS guided for $2.3â2.4B in 2025 revenue, showing confidence in continued scale, especially as demand for GLP-1s and accessible healthcare explodes. XXX engagements  **Related Topics** [hims](/topic/hims) [weight loss](/topic/weight-loss) [quarterly earnings](/topic/quarterly-earnings) [$hims](/topic/$hims) [hims hers](/topic/hims-hers) [stocks consumer defensive](/topic/stocks-consumer-defensive) [Post Link](https://x.com/AkinatorAssets/status/1942972931992174723)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Akinator Assets @AkinatorAssets on x XXX followers
Created: 2025-07-09 15:43:40 UTC
đ§”3/ BULL CASE â $HIMS
đ BULL CASE:
1.Exceptional Revenue Growth Trajectory: $HIMS has delivered XXXXX% YoY revenue growth. Its Q1 2025 earnings highlighted âmillions of people turning to usâ and âincredible momentumâ â a clear signal of strong consumer adoption and traction.
2.GLP-1 Expansion Success: $HIMS is a key player in offering FDA-approved GLP-1 medications for weight loss via telehealth. With personalized plans and licensed professionals, management expects $725M in weight loss revenue alone in 2025.
3.Industry Tailwinds: The global telehealth market is projected to reach $455.27B by 2030, growing at XXXXX% CAGR. $HIMS is well-positioned to capture a meaningful share of that pie.
4.Strong Profitability Metrics: Despite being a high-growth company, $HIMS is already posting a XXXX% profit margin, outperforming peers who are still bleeding cash for growth.
5.Aggressive Revenue Guidance: $HIMS guided for $2.3â2.4B in 2025 revenue, showing confidence in continued scale, especially as demand for GLP-1s and accessible healthcare explodes.
XXX engagements
Related Topics hims weight loss quarterly earnings $hims hims hers stocks consumer defensive
/post/tweet::1942972931992174723